Draganfly Deploys Advanced Commander 3XL and Commences Training with Squamish Search and Rescue
Newsfilter· 2024-08-07 05:05
Delivery of Advanced Commander 3XL and Precision Delivery System Marks Key Milestone Squamish, BC., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce the delivery of its newest Advanced First Responder assets to Squamish Search and Rescue (SSAR), inclusive of the Commander 3XL drone and modular payloads. This delivery marks a significant step in ...
Ashland reports financial results1 for third quarter fiscal 2024, issues outlook for fourth quarter and full-year fiscal 2024
Newsfilter· 2024-08-07 05:01
Sales of $544 millionNet income (including discontinued operations) of $6 million, or $0.12 per diluted shareIncome from continuing operations of $31 million, or $0.60 per diluted shareAdjusted income from continuing operations excluding intangibles amortization expense of $75 million, or $1.49 per diluted shareAdjusted EBITDA of $139 million, up five percent from the prior-year quarterCash flows provided by operating activities of $128 million; ongoing free cash flow2 of $112 millionRepurchased 1.3 million ...
Aeries Technology Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
Newsfilter· 2024-08-07 05:00
NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. ("Aeries" or "the Company") (NASDAQ:AERT), a global professional services and technology consulting partner, today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") on July 31, 2024 ( the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of its failure t ...
American Lithium Appoints New CFO
Newsfilter· 2024-08-07 05:00
VANCOUVER, British Columbia, Aug. 06, 2024 (GLOBE NEWSWIRE) -- American Lithium Corp. ("American Lithium" or the "Company") (TSXV:LI, NASDAQ:AMLI, Frankfurt:5LA1))) is pleased to announce the appointment of Paul Charlish as Chief Financial Officer (CFO) effective August 1, 2024. Mr. Charlish, most recently served as Vice President Finance and Corporate Secretary of American Lithium, and has over 35 years of financial experience, including audit and tax in public practice, as well as financial reporting and ...
Ring Energy Announces Second Quarter 2024 Results, Provides Guidance for Third Quarter and Updates Full Year 2024 Outlook
Newsfilter· 2024-08-07 04:45
THE WOODLANDS, Texas, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) ("Ring" or the "Company") today reported operational and financial results for second quarter 2024 and provided an improved outlook for the third quarter and full year. Second Quarter 2024 Highlights Produced sales of 13,623 barrels of oil per day ("Bo/d"), representing a 2% increase over the first quarter of 2024; Sold record total volumes of 19,786 barrels of oil equivalent per day ("Boe/d") (69% oil), which was ...
BioVie Inc. Announces Reverse Stock Split
Newsfilter· 2024-08-07 04:40
CARSON CITY, Nev., Aug. 06, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or the "Company") today announced that the Company's reverse stock split of its issued and outstanding Class A common stock ("Common Stock"), at an exchange ratio of 1-for-10, is now effective. The Company's Common Stock began trading on a split-adjusted basis and will remain listed on The Nasdaq Capital Market under the symbol "BIVI". The new CUSIP number for the Company's Common Stock following the reverse stock spli ...
Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024
Newsfilter· 2024-08-07 04:36
NEWTOWN, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Company will release its second quarter 2024 financial results on Monday, August 12, 2024, after the market closes. Dane C. Andreeff, President and Chief Executive Officer, and Jeffrey S. Mathiesen, Chief Financial Officer will host a conferen ...
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024
Newsfilter· 2024-08-07 04:31
文章核心观点 - 芬尼克制药公司将于2024年8月13日发布2024年第二季度财务业绩报告并提供业务更新[1] - 公司将参加2024年8月13-14日在纽约举行的2024年Wedbush PacGrow医疗保健会议[3] - 公司专注于开发和商业化PEDMARK®和Pedmarqsi,以降低白金类化疗药物导致的儿童患者听力损害风险[4] - PEDMARK已于2022年9月获得FDA批准,2023年6月获得欧盟市场准入授权,并获得7年的市场独占权[4] 财务业绩报告 - 公司将于2024年8月13日发布2024年第二季度财务业绩报告[1] - 公司将在当天举行电话会议和网络直播,讨论公司的财务和业务情况[1][2] 会议参与 - 公司将参加2024年8月13-14日在纽约举行的2024年Wedbush PacGrow医疗保健会议[3]
byNordic Acquisition Corporation Signs Letter of Intent for Business Combination with Sivers Semiconductors' Wholly Owned Photonics Subsidiary
Newsfilter· 2024-08-07 04:30
NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- byNordic Acquisition Corporation (("byNordic", NASDAQ:BYNO), a publicly traded special purpose acquisition company, has signed a non-binding Letter of Intent (LOI) with Sivers Semiconductors AB ("Sivers", STO: SIVE), a leading supplier of wireless and photonic integrated chips and modules for communications and sensor solutions, to merge its wholly owned Sivers Photonics Ltd subsidiary ("Sivers Photonics") with byNordic. Sivers Photonics designs and manufactures a ...
UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates
Newsfilter· 2024-08-07 04:30
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) (NASDAQ:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the second quarter ended June 30, 2024. "Having expanded and extended our ASPIRE study to 50 patients and 36 weeks, respectively, to better assess the efficacy and durability of UBX1325 compared to aflibercept, we have been laser-focused on enrollment and execution this ...